Table of Contents

2019-2024 Global Tuberculosis Diagnostics and Treatment Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tuberculosis Diagnostics and Treatment Market Size 2014-2024
2.1.2 Tuberculosis Diagnostics and Treatment Market Size CAGR by Region
2.2 Tuberculosis Diagnostics and Treatment Segment by Type
2.2.1 Skin Testing
2.2.2 Laboratory Testing
2.3 Tuberculosis Diagnostics and Treatment Market Size by Type
2.3.1 Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2014-2019)
2.3.2 Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Type (2014-2019)
2.4 Tuberculosis Diagnostics and Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Tuberculosis Diagnostics and Treatment Market Size by Application
2.5.1 Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2014-2019)
2.5.2 Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Application (2014-2019)

3 Global Tuberculosis Diagnostics and Treatment by Players
3.1 Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Players
3.1.1 Global Tuberculosis Diagnostics and Treatment Market Size by Players (2017-2019)
3.1.2 Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Players (2017-2019)
3.2 Global Tuberculosis Diagnostics and Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Tuberculosis Diagnostics and Treatment by Regions
4.1 Tuberculosis Diagnostics and Treatment Market Size by Regions
4.2 Americas Tuberculosis Diagnostics and Treatment Market Size Growth
4.3 APAC Tuberculosis Diagnostics and Treatment Market Size Growth
4.4 Europe Tuberculosis Diagnostics and Treatment Market Size Growth
4.5 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size Growth

5 Americas
5.1 Americas Tuberculosis Diagnostics and Treatment Market Size by Countries
5.2 Americas Tuberculosis Diagnostics and Treatment Market Size by Type
5.3 Americas Tuberculosis Diagnostics and Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Tuberculosis Diagnostics and Treatment Market Size by Countries
6.2 APAC Tuberculosis Diagnostics and Treatment Market Size by Type
6.3 APAC Tuberculosis Diagnostics and Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Tuberculosis Diagnostics and Treatment by Countries
7.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Type
7.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Tuberculosis Diagnostics and Treatment by Countries
8.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type
8.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Tuberculosis Diagnostics and Treatment Market Forecast
10.1 Global Tuberculosis Diagnostics and Treatment Market Size Forecast (2019-2024)
10.2 Global Tuberculosis Diagnostics and Treatment Forecast by Regions
10.2.1 Global Tuberculosis Diagnostics and Treatment Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Tuberculosis Diagnostics and Treatment Forecast by Type
10.8 Global Tuberculosis Diagnostics and Treatment Forecast by Application

11 Key Players Analysis
11.1 Cepheid Inc
11.1.1 Company Details
11.1.2 Tuberculosis Diagnostics and Treatment Product Offered
11.1.3 Cepheid Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Cepheid Inc News
11.2 Becton Dickinson
11.2.1 Company Details
11.2.2 Tuberculosis Diagnostics and Treatment Product Offered
11.2.3 Becton Dickinson Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Becton Dickinson News
11.3 Hain LifeSciences
11.3.1 Company Details
11.3.2 Tuberculosis Diagnostics and Treatment Product Offered
11.3.3 Hain LifeSciences Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Hain LifeSciences News
11.4 Abbott Laboratories
11.4.1 Company Details
11.4.2 Tuberculosis Diagnostics and Treatment Product Offered
11.4.3 Abbott Laboratories Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Abbott Laboratories News
11.5 Alere, Inc
11.5.1 Company Details
11.5.2 Tuberculosis Diagnostics and Treatment Product Offered
11.5.3 Alere, Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Alere, Inc News
11.6 Roche AG
11.6.1 Company Details
11.6.2 Tuberculosis Diagnostics and Treatment Product Offered
11.6.3 Roche AG Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Roche AG News
11.7 Hologic Corporation
11.7.1 Company Details
11.7.2 Tuberculosis Diagnostics and Treatment Product Offered
11.7.3 Hologic Corporation Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Hologic Corporation News
11.8 bioMerieux
11.8.1 Company Details
11.8.2 Tuberculosis Diagnostics and Treatment Product Offered
11.8.3 bioMerieux Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 bioMerieux News
11.9 Sanofi
11.9.1 Company Details
11.9.2 Tuberculosis Diagnostics and Treatment Product Offered
11.9.3 Sanofi Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Sanofi News
11.10 QIAGEN
11.10.1 Company Details
11.10.2 Tuberculosis Diagnostics and Treatment Product Offered
11.10.3 QIAGEN Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 QIAGEN News
11.11 Akonni Biosystems, Inc.
11.12 Epistem Holdings Plc
11.13 Gen-Probe Inc.
11.14 EIKEN Chemical
11.15 Thermo Fisher Scientific, Inc

12 Research Findings and Conclusion